Compare CRNX & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | MHH |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 81.7M |
| IPO Year | 2018 | 2008 |
| Metric | CRNX | MHH |
|---|---|---|
| Price | $38.38 | $6.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $76.63 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 8.9K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $1,039,000.00 | ★ $191,371,000.00 |
| Revenue This Year | $720.10 | $2.93 |
| Revenue Next Year | $184.67 | $8.93 |
| P/E Ratio | ★ N/A | $116.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.10 | $5.51 |
| 52 Week High | $57.99 | $9.02 |
| Indicator | CRNX | MHH |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 55.20 |
| Support Level | $33.19 | $5.52 |
| Resistance Level | $45.32 | $7.59 |
| Average True Range (ATR) | 1.72 | 0.42 |
| MACD | 0.67 | 0.03 |
| Stochastic Oscillator | 92.34 | 64.49 |
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.